Literature DB >> 11105079

Toxoplasma gondii myelitis in a patient with adult T-cell leukemia-lymphoma.

E Maciel1, I Siqueira, A C Queiroz, A Melo.   

Abstract

Adult T cell leukemia-lymphoma (ATL) caused by HTLV-I may be associated with severe immunosupression and several opportunistic infections. Toxoplasmic encephalitis is a common central nervous system opportunistic infection in severely immunosupressed patients, however spinal cord involvement by this parasite is rare. In this paper, we report a case of toxoplasmic myelitis in a patient with ATL.

Entities:  

Mesh：

Year:  2000        PMID： 11105079     DOI： 10.1590/s0004-282x2000000600019

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN： 0004-282X            Impact factor:   1.420


  9 in total

1.  Spinal cord pathology in chronic experimental Toxoplasma gondii infection.

Authors:  L Möhle; A Parlog; J Pahnke; I R Dunay
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

2.  Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level.

Authors:  Mona Ibrahim Ali; Wegdan Mohamed Abd El Wahab; Doaa Ahmed Hamdy; Ahmed Hassan
Journal:  J Parasit Dis       Date:  2019-03-30

3.  Spinal Cord Lesions in Congenital Toxoplasmosis Demonstrated with Neuroimaging, Including Their Successful Treatment in an Adult.

Authors:  Delilah Burrowes; Kenneth Boyer; Charles N Swisher; A Gwendolyn Noble; Mari Sautter; Peter Heydemann; Peter Rabiah; Daniel Lee; Rima McLeod
Journal:  J Neuroparasitology       Date:  2012-03

Review 4.  Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review.

Authors:  S Scerra; H Coignard-Biehler; F Lanternier; F Suarez; C Charlier-Woerther; M-E Bougnoux; J Gilquin; M Lecuit; O Hermine; O Lortholary
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-18       Impact factor: 3.267

5.  Spinal cord toxoplasmosis in a young immunocompetent patient.

Authors:  M Martinot; V Greigert; C Farnarier; M L Dardé; C Piperoglou; M Mohseni-Zadeh; J Tarabeux; A Guffroy; O Villard; F Vely
Journal:  Infection       Date:  2019-12-09       Impact factor: 3.553

6.  Toxoplasmic Encephalitis with Untreated Hairy Cell Leukemia Variant.

Authors:  Taichi Ikebe; Hitohiro Sasaki; Hiroyuki Takata; Yasuhiko Miyazaki; Eiichi Ohtsuka; Yoshio Saburi; Masao Ogata; Kuniaki Shirao
Journal:  Intern Med       Date:  2016-11-01       Impact factor: 1.271

7.  Toxoplasma gondii Infection in Immunocompromised Patients: A Systematic Review and Meta-Analysis.

Authors:  Ze-Dong Wang; Huan-Huan Liu; Zhan-Xi Ma; Hong-Yu Ma; Zhong-Yu Li; Zhi-Bin Yang; Xing-Quan Zhu; Bin Xu; Feng Wei; Quan Liu
Journal:  Front Microbiol       Date:  2017-03-09       Impact factor: 5.640

8.  Toxoplasmosis an Overlooked Disease: Seroprevalence in Cancer Patients

Authors:  Raafat Abdel Malek; Rita Wassef; Enas Rizk; Hoda Sabry; Nevine Tadros; Abdallah Boghdady
Journal:  Asian Pac J Cancer Prev       Date:  2018-07-27

9.  The Toxoplasma gondii ME-49 strain upregulates levels of A20 that inhibit NF-κB activation and promotes apoptosis in human leukaemia T-cell lines.

Authors:  Qian Chen; Min-Hui Pang; Xiao-Hong Ye; Guang Yang; Chen Lin
Journal:  Parasit Vectors       Date:  2018-05-18       Impact factor: 3.876
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.